» Articles » PMID: 10763643

Incidence of Weight Loss in Head and Neck Cancer Patients on Commencing Radiotherapy Treatment at a Regional Oncology Centre

Overview
Publisher Wiley
Specialties Nursing
Oncology
Date 2000 Apr 14
PMID 10763643
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this prospective study was to investigate the incidence of weight loss in head and neck cancer patients on commencing radiotherapy treatment at a regional oncology centre. Of the 100 patients included in the study, 33% presented with carcinoma of the larynx. Fifty-seven per cent of patients had lost weight on commencing treatment. A mean weight loss of 6.5 kg, equating to approximately 10% of body weight, was reported. A significant number of patients experienced a dry and/or sore mouth, had difficulty masticating and swallowing food, had altered taste perception, were missing meals or had symptoms of uncontrollable nausea and constipation. Since radiotherapy treatment may further limit oral intake, it is essential that dietetic intervention is addressed for all head and neck cancer patients and incorporated into the treatment plan on diagnosis before definitive management commences.

Citing Articles

Smoking cessation interventions in patients diagnosed with head and neck cancers: A systematic review of randomized controlled trials.

Gaikwad R, Alqifari F, Alnasser M, Bajad P, Jain P, Gondivkar S Int J Health Sci (Qassim). 2023; 17(5):45-53.

PMID: 37692993 PMC: 10484062.


Routine Prophylactic Percutaneous Endoscopic Gastrostomy in Head and Neck Cancers with Bilateral Neck Irradiation: A Regional Cancer Experience in New Zealand.

Fong S, Pandey R, Rajaretnam M, Delaibatiki M, Peel D J Med Radiat Sci. 2023; 70(3):292-300.

PMID: 37403761 PMC: 10500120. DOI: 10.1002/jmrs.699.


Nutritional Management of Patients with Head and Neck Cancer-A Comprehensive Review.

Martinovic D, Tokic D, Puizina Mladinic E, Usljebrka M, Kadic S, Lesin A Nutrients. 2023; 15(8).

PMID: 37111081 PMC: 10144914. DOI: 10.3390/nu15081864.


Exosomal Plasminogen Activator Inhibitor-1 Induces Ionizing Radiation-Adaptive Glioblastoma Cachexia.

Shin E, Kang H, Lee H, Lee S, Jeon J, Seong K Cells. 2022; 11(19).

PMID: 36231065 PMC: 9564109. DOI: 10.3390/cells11193102.


Pathophysiology of cachexia and characteristics of dysphagia in chronic diseases.

Matsuo H, Sakuma K Asia Pac J Oncol Nurs. 2022; 9(10):100120.

PMID: 36118624 PMC: 9471339. DOI: 10.1016/j.apjon.2022.100120.